Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1612-1618

  Mortara, Andrea ^a   La Rovere, Maria Teresa ^a   Pinna, Gian Domenico ^a   Maestri, Roberto ^a   Capomolla, Soccorso ^a   Cobelli, Franco ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; VASODILATOR AGENT;

ADULT; AMBULATORY MONITORING; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; HEART FAILURE; HEART RATE; HOLTER MONITORING; HUMAN; META ANALYSIS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; BAROREFLEX; CARBAZOLES; CASE-CONTROL STUDIES; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MIDDLE AGED; PROPANOLAMINES;

EID: 0034332846     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00900-1     Document Type: Article

References (40)

1. Clinical effects of beta-adrenergic blockade in chronic heart failure. A meta-analysis of double blind, placebo-controlled, randomized trials
2. Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials
3. Effects of beta-blocker therapy on mortality in patients with heart failure: A systematic overview of randomized controlled trials
4. Carvedilol
5. Heart rate variability. Standards of measurement, physiological interpretation and clinical use
6. Arterial baroreflexes in humans
7. Baroreflex sensitivity
8. Heart rate variability and cardiac failure
9. Congestive heart failure
10. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart)
11. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications
12. Effect of atenolol and diltiazem on heart period variability in normal persons
13. Effect of beta-blockade on heart rate variability in patients with coronary artery disease
14. Effects of beta-blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction
15. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients
16. Influence of metoprolol on heart rate variability in survivors of remote myocardial infarction
17. Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction
18. Beta-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects
19. Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans
20. Sympathetic restraint of baroreflex control of heart period in normotensive and hypertensive subjects
21. Beta-adrenergic blocking treatment and 24-h baroreflex sensitivity in essential hypertensive patients
22. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary disease
23. Effects of bisoprolol on heart rate variability in heart failure
24. Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure
25. Effect of beta-blockade on baroreceptor and autonomic function in heart failure
26. Reflex regulation of arterial pressure during sleep in man: A quantitative method for assessing baroreflex sensitivity
27. Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary disease
28. Cardiac adrenergic receptor effects of carvedilol
29. Comparative hemodynamic, left ventricular function and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
30. Pathophysiology of heart failure
31. Effects of autonomic blockade on the baroreflexes in man at rest and during exercise
32. Modulation of carotid baroreflex responsiveness in man: Effects of posture and propanolol
33. Autonomic pathophysiology in heart failure: Carotid baroreceptor-cardiac reflexes
34. Abnormalities of baroreflex control in heart failure
35. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
36. Origin of respiratory sinus arrhythmias in conscious humans. An important role for arterial carotid baroreceptors
37. Physiology and pathophysiology of heart rate and blood pressure variability in humans: Is power spectral analysis largely an index of baroreflex gain?
38. Is respiratory sinus arrhythmia a good index of cardiac vagal tone in exercise?
39. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation
40. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure